EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Glasgow prognostic score as a predictor of decompensation in patients with primary biliary cholangitis

Man Huang, Feng Guo, Li-Gong Bian, Chang-Hui Wu, Wen Zou, De Duan, Yuan Tang, Shun-Yu Chen, Meng-Yao Zheng, Jun-Kun Niu, Hong-Tao Lei

World Journal of Gastroenterology · 2027-01-07 · 33 (1)

DOI: 10.3748/wjg.123000 ↗
AbstractBibliografische Angaben

Abstract

BACKGROUND Inflammatory activity and nutritional status are closely associated with the progression of primary biliary cholangitis (PBC) and other chronic liver diseases. AIM To determine the predictive performance of the Glasgow prognostic score (GPS), modified GPS (mGPS), and high-sensitivity mGPS (hs-mGPS) for hepatic decompensation in PBC. METHODS We performed a multicenter retrospective cohort study involving patients diagnosed with compensated PBC at seven hospitals between January 2013 and December 2024. GPS, mGPS, and hs-mGPS were calculated using baseline measurements of C-reactive protein (CRP), high-sensitivity CRP, and albumin levels. The endpoint was the first occurrence of hepatic decompensation during follow-up. Time-dependent receiver operating characteristic curves (ROCs) were used to compare the predictive performance of the GPS, mGPS, hs-mGPS, Paris I, Paris II, Mayo, United Kingdom-PBC (UK-PBC), and GLOBE scores for decompensation events. RESULTS This analysis included 762 patients with compensated PBC. The median age was 56 years (interquartile range: 49-66), and 606 patients (79.5%) were female. Kaplan-Meier analysis showed that the 5-year decompensation rates increased progressively across higher score strata for all three indices (P < 0.0001 for all). In fully adjusted multivariate models, GPS (hazard ratio [HR] = 3.605, 95% confidence interval [CI]: 2.783-4.670), mGPS (HR = 3.103, 95%CI: 2.469-3.900), and hs-mGPS (HR = 3.261, 95%CI: 2.549-4.171) independently predicted decompensation risk (P < 0.0001 for all). Time-dependent ROC analysis indicated that the GPS score yielded the highest area under the curve (0.754) for predicting decompensation, followed by hs-mGPS (0.725), mGPS (0.696), GLOBE (0.663), UK-PBC (0.638), Mayo (0.624), Paris I (0.597), and Paris II (0.582), whereas the difference between GPS and hsmGPS was not statistically significant. CONCLUSION GPS, mGPS, and hs-mGPS are independent prognostic markers for decompensation in PBC. The GPS has the strongest predictive accuracy, supporting its potential clinical utility in early risk stratification and management guidance.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →